InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by 이희용, Chairman & CEO. Insider active across 2 companies, notably 지투지바이오. Aggregated, 15 filings have been published. Activity tracked since 25 March 2026. The latest transaction was filed on 25 March 2026 (Purchase). Regulator: DART (FSS). The full history is free.
15 of 15 declarations
Lee Hee-Yong is the Chairman & CEO of 지투지바이오, a company focused on biopharmaceutical development. His leadership is crucial in guiding the company in its innovation and research efforts. He plays a key role in defining strategy and promoting the sustainable growth of the company.